TIHA × Hope AI | JPM 2026 Innovation Summit
TIHA × Hope AI | JPM 2026 Innovation Summit
Empowering Drug Development & Global BD
Hosted By
TIHA — The International Healthcare Alliance
Hope AI
Date & Time
January 14, 2026 (Wednesday)
1:00 PM – 5:00 PM
Location
San Francisco Financial District (Near Union Square)
(Venue details shared after registration)
🚀 About the Summit
The TIHA × Hope AI JPM 2026 Innovation Summit is a high-value gathering connecting AI innovators, drug development leaders, BD teams, clinical-asset owners, and investors shaping the future of global healthcare.
Aligned with the momentum of JPM Week, this curated event focuses on two major themes that will define the next decade of innovation:
AI × Drug Development
Cross-Border BD / Licensing Opportunities
TIHA and Hope AI co-host this summit as part of our mission to advance international collaboration, practical innovation, and strategic partnerships across the U.S., Asia, and global markets.
🎤 Program Themes
🔹 TOPIC 1 — AI × Drug Development
How AI and ecosystem connectivity are transforming discovery, automation, and R&D strategy:
AI Acceleration & Lab Automation
The Evolving Role of CROs/CDMOs
Investment Insights in AI for Bio
The Power of Ecosystems in Accelerating Drug Development
How curated networks, cross-border partnerships, and innovation communities bridge AI platforms, wet-lab execution, BD readiness, and global market access.
🔹 TOPIC 2 — Cross-Border Transactions & Global BD
Practical insights for companies engaging in international deals:
China–US Clinical Asset Trends
Pharma BD Strategies for 2026
Out-Licensing Preparation & Case Studies
🌟 NEW: Invitation for Licensing Programs & Clinical-Asset Owners
We welcome teams with:
• Phase 1–3 assets
• Platform technologies
• Cross-border licensing programs
If you have assets available for:
Out-licensing
Co-development
Regional partnerships
In-licensing exploration
Please indicate your interest in the registration form. Our team will follow up to discuss a short presentation opportunity.
👥 Who Should Attend
Ideal for:
AI & drug discovery platforms
Biopharma founders and scientific leaders
Pharma BD & licensing teams
Investors (VCs, FOs, CVCs)
CRO/CDMO executives
Clinical-asset owners seeking global partners
Teams exploring U.S.–China or international market entry
🤝 Open for Collaboration
Co-hosted by TIHA × Hope AI, we welcome:
Speakers | Sponsors | Strategic Partners
About TIHA (The International Healthcare Alliance)
TIHA is a Boston-based nonprofit platform dedicated to advancing global collaboration across biopharma, healthcare, and AI-driven innovation. Operating under Eastwest Healthcare Alliance Inc., TIHA connects a growing international community of leaders, researchers, entrepreneurs, and investors.
During JPM Week, TIHA serves as a trusted bridge for cross-border partnerships, licensing opportunities, and innovation exchange. Through forums, BD matchmaking, expert workshops, and global programs, TIHA helps accelerate discovery, commercialization, and market access worldwide.
About Hope AI
Hope AI accelerates the clinical development of life-saving treatments through AI-powered trial design and execution. Our AI assistants work alongside clinical teams to enable faster, more data-driven decisions, improving success rates and reducing time to market.
Hope AI envisions a future where promising drug candidates can be tested efficiently through AI-enabled clinical trials and delivered more rapidly to patients in need.
⚠️ Disclaimer
📸 Photos and video recordings may be taken during the event and used for promotional purposes.
📝 Program topics, speakers, and schedule are subject to change without prior notice.
⚖️ This event does not constitute investment advice or solicitation. All discussions are for informational and educational purposes only.
🔒 By registering for and attending this event, you consent to the sharing of your registration information with the event organizers and event sponsors for event-related communications and follow-up.